HCP = healthcare professional.
References: 1. Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus of practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Eur J Endocrinol. 2022;186(2):R33-R63. doi:10.1530/EJE-21-1044
2. Sanders JE, Sliney J. Advocacy and hypoparathyroidism in the twenty-first century. In: Brandi ML, Brown EM, eds. Hypoparathyroidism. Springer, Milano. 2015:407-414. doi:10.1007/978-88-470-5376-2_38
3. Alexander JA, Hearld LR, Mittler JN, et al. Patient-physician role relationships and patient activation among individuals with chronic illness. Health Serv Res. 2012;47(3, pt 1):1201-1223. doi:10.1111/j.1475-6773.2011.01354.x
4. Tamhane S, Rodriguez-Gutierrez R, Hargraves I, et al. Shared decision-making in diabetes care. Curr Diab Rep. 2015;15(12):112. doi:10.1007/s11892-015-0688-0
5. Mannstadt M, Bilezikian JP, Thakker RV, et al. Hypoparathyroidism. Nat Rev Dis Primers. 2017;3:17055. doi:10.1038/nrdp.2017.55
6. Bilezikian JP, Brandi ML, Cusano NE, et al. Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab. 2016;101(6);2313-2324. doi:10.1210/jc.2015-3910
7. Orloff LA, Wiseman SM, Bernet VJ, et al. American Thyroid Association Statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid. 2018;28(7):830-841. doi:10.1089/thy.2017.0309
8. Brod M, Waldman LT, Smith A, et al. Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact). Qual Life Res. 2021;30(1):277-291. doi:10.1007/s11136-020-02607-1
© October 2022 Ascendis Pharma Endocrinology, Inc. All rights
reserved.
Ascendis®, KnowHypoPara™, the Ascendis
Pharma logo and the company logo are trademarks owned by the
Ascendis Pharma group.
US-COMM-2200023 10/22